HemCon Medical Technologies

 Company Summary:
  • HemCon Medical Technologies develops and markets innovative technologies addressing wound care from closure to treatment. HemCon products are designed for medical professionals in hospital, dental and clinical settings, as well as by military and civilian first responders where rapid control of bleeding is of critical importance. 
Transaction Overview: Significance of the Transaction:
  • The acquisition allows Tricol to establish entry into the wound care market and enables HemCon wound closure device access to other high growth markets such as surgical and chronic wound care.
Healthios Role:
  • Healthios served as exclusive strategic adviser to HemCon Medical Technologies.
  • This transaction demonstrates Healthios’ continued leadership as the "advisor of choice" to maximize company value at various steps of the emerging growth progression by leveraging relationships with a wide range of well-positioned Strategics.